July 2008-June 2009
FY 2009 Research & Sponsored Program Funding
Listed alphabetically by principal investigator
Investigators |
Title |
Sponsor |
Start |
End |
Amount |
|
Alter, Gerald M. |
Graduate Research Assistant Support--Kolawole |
Central State University |
9/1/08 |
8/31/09 |
$19,200 |
|
Alvarez, Francisco J. |
Development of Synaptic Inputs on Spinal Interneurons |
DHHS, National Institute of Neurological Disorders and Stroke (NINDS) |
2/1/09 |
1/31/10 |
$313,906 |
|
Alvarez, Francisco J.; Alvarez-Leefmans, F. Javier |
Multi Photon Laser Microscope for Neuroscience Research Imaging Core Facility |
DHHS, National Center for Research Resources (NCRR) |
5/1/09 |
4/30/10 |
$718,089 |
|
Alvarez, Francisco J. |
Benzodiazepine-Induced Glutamate Receptor Plasticity |
University of Toledo |
4/1/09 |
3/31/10 |
$20,000 |
|
Anstadt, Mark P.; Reynolds, David B. |
New Heart Failure Treatment Capability for Remote Environments |
MYOTECH, LLC |
7/14/08 |
8/13/11 |
$285,268 |
|
Ballester, J. Michael; Gataric, Gordana |
AGS/Hartford Project: Geriatric Education for Specialty Residents |
American Geriatrics Society (The) |
7/1/08 |
6/30/09 |
$20,000 |
|
Baumann, Michael A.; Paul, Cassandra C. |
License Agreement for AML14 and AML14.3D10 Cell Lines |
AstraZeneca |
5/1/08 |
5/31/09 |
$10,000 |
|
Baumann, Michael A.; Paul, Cassandra C. |
License Agreement for AML14 and AML14.3D10 Cell Lines |
Michigan State University |
5/1/08 |
5/31/12 |
$1,500 |
|
Baumann, Michael A.; Paul, Cassandra C. |
License Agreement for AML14 and AML14.3D10 Cell Lines |
Hoffman-LaRoche, Inc. |
11/7/08 |
11/6/11 |
$40,000 |
|
Berberich, Steven J. |
Deciphering How Mdmx Deregulation Impacts the p53 Pathway |
DHHS, National Cancer Institute (NCI) |
12/1/08 |
11/30/09 |
$193,576 |
|
Berberich, Steven J. |
Deciphering How Mdmx Deregulation Impacts the p53 Pathway |
DHHS, National Cancer Institute (NCI) |
12/1/08 |
11/30/09 |
$21,508 |
|
Bienenfeld, David G. |
Psychiatric Residency Training and Community Outreach |
Ohio Department of Mental Health |
7/1/08 |
6/30/09 |
$30,000 |
|
Bienenfeld, David G. |
Improving Ohio's Psychiatric Workforce through Collaboration with the WSU Dept. of Psychiatry |
Ohio Department of Mental Health |
7/1/08 |
6/30/09 |
$130,000 |
|
Boivin, Gregory |
Mouse Models of Gastrointestinal Cancer |
Ohio State University |
6/15/08 |
3/31/09 |
$50,000 |
|
Boivin, Gregory |
Traumatic Lung Injury (TLI) |
Spectral Energetics, Inc. |
9/10/08 |
12/9/08 |
$5,658 |
|
Boivin, Gregory |
NIRVANA Project |
Spectral Energetics, Inc. |
12/8/08 |
9/7/09 |
$46,460 |
|
Boivin, Gregory; Cool, David R. |
Purified Snake Venom Study |
Central State University |
2/1/09 |
6/30/09 |
$10,171 |
|
Boivin, Gregory |
Traumatic Lung Injury (TLI) |
Spectral Energetics, Inc. |
9/10/08 |
12/9/08 |
$7,048 |
|
Carlson, Robert G.; Wang, Jichuan |
Rural Stimulant Use and Mental Health: Services and Outcomes |
University of Arkansas |
7/1/08 |
6/30/09 |
$90,000 |
|
Carlson, Robert G.; Falck, Russel S. |
Trajectories of Illicit Pharmaceutical Opioid Use Among Young Adults in Ohio |
DHHS, National Institute on Drug Abuse (NIDA) |
2/1/09 |
1/31/10 |
$571,868 |
|
Carlson, Robert G.; Falck, Russel S. |
Trajectories of Illicit Pharmaceutical Opioid Use Among Young Adults in Ohio |
DHHS, National Institute on Drug Abuse (NIDA) |
2/1/09 |
1/31/10 |
$63,541 |
|
Cauley, Katherine L. |
AHEC Support |
Ohio Board of Regents |
7/1/08 |
6/30/09 |
$45,182 |
|
Cauley, Katherine L. |
Sinclair Community College Matching Funds: CY2004 |
Sinclair Community College |
7/1/04 |
12/31/04 |
$18,511 |
|
Cauley, Katherine L. |
Sinclair Community College Matching Funds: CY2008 |
Sinclair Community College |
7/1/08 |
12/31/08 |
$16,489 |
|
Cauley, Katherine L. |
AHEC Support |
Ohio Board of Regents |
7/1/08 |
6/30/09 |
$42,320 |
|
Cauley, Katherine L. |
Southeast Weed & Seed Safe Haven Programming |
Montgomery County Sunrise Center |
10/1/08 |
9/30/09 |
$5,000 |
|
Cauley, Katherine L. |
Kinship Navigator Consortium |
Montgomery County Children Services |
1/1/09 |
12/31/09 |
$126,641 |
|
Cauley, Katherine L. |
Consulting Services - Health Policy Institute of Ohio (HPIO) |
Health Policy Institute of Ohio |
4/1/08 |
3/31/09 |
$20,507 |
|
Cauley, Katherine L. |
Sinclair Community College Matching Funds: CY2009 |
Sinclair Community College |
1/1/09 |
12/31/09 |
$35,000 |
|
Cauley, Katherine L. |
AHEC Support |
Ohio Board of Regents |
7/1/08 |
6/30/09 |
$37,372 |
|
Cauley, Katherine L. |
Testing and Demonstrations of the National Health Information Network (NHIN) Trial Implementations through HealthLink RHIO at Wright State University |
DHHS, National Library of Medicine (NLM) |
5/1/09 |
4/30/10 |
$96,305 |
|
Cauley, Katherine L. |
Consulting Services - Health Policy Institute of Ohio (HPIO) |
Health Policy Institute of Ohio |
4/1/08 |
4/15/09 |
$3,189 |
|
Cauley, Katherine L. |
AHEC Support |
Ohio Board of Regents |
7/1/08 |
6/30/09 |
$37,372 |
|
Clasen, Carla |
Ryan White Planning & Evaluation |
Public Health Dayton and Montgomery County (formerly Montgomery County Combined Health District) |
8/1/08 |
3/31/09 |
$1,500 |
|
Clasen, Carla |
Ryan White Planning & Evaluation |
Lucas County Regional Health District |
10/1/08 |
3/31/09 |
$1,500 |
|
Cope, Timothy C. |
Synaptic Function: Effects of Nerve Injury, Repair, and Altered Activity |
DHHS, National Institute of Neurological Disorders and Stroke (NINDS) |
9/15/07 |
8/31/09 |
$88,375 |
|
Cope, Timothy C.; Alvarez, Francisco J. |
Synaptic Function: Effects of the Nerve Injury, and Altered Activity |
DHHS, National Institute of Neurological Disorders and Stroke (NINDS) |
9/1/08 |
8/31/09 |
$901,328 |
|
Cope, Timothy C. |
Functional Assemblies of Motor Units |
DHHS, National Institute of Neurological Disorders and Stroke (NINDS) |
3/1/09 |
2/28/10 |
$319,689 |
|
Czerwinski, Stefan Aleksander; Siervogel, Roger M. |
Genetic Analysis of Osteoporosis Risk Factors |
DHHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) |
7/1/08 |
6/30/09 |
$425,169 |
|
Dodge, Robin E. |
Aerospace Medicine Training for the Era of Moon, Mars, and Beyond |
National Aeronautics and Space Administration |
2/8/09 |
2/7/10 |
$430,000 |
|
Dunn, Margaret M. |
Miscellaneous Awards under DCOP Fiscal Agency Agreement |
Dayton Clinical Oncology Program (DCOP) |
6/1/07 |
5/31/08 |
$126,455 |
|
Dunn, Margaret M. |
NCI Award under DCOP Fiscal Agency Agreement |
Dayton Clinical Oncology Program (DCOP) |
6/1/09 |
5/31/10 |
$955,208 |
|
Duren, Dana L.; Siervogel, Roger M. |
Genetic, Somatic, and Maturational Influences on Pediatric Skeletal Health |
DHHS, National Institute of Child Health and Human Development (NICHD) |
8/1/08 |
7/31/09 |
$283,216 |
|
Elased, Khalid M. |
Ah Receptor and Endothelin-Dependent Hypertension |
University of New Mexico |
3/1/08 |
2/28/09 |
$57,400 |
|
Elased, Khalid M. |
Role of Angiotensin Converting Enzyme 1 (ACE1) and ACE2 in the Regulation of Blood Pressure in Diabetes |
American Heart Association - National |
7/1/08 |
6/30/09 |
$65,000 |
|
Falck, Russel S.; Carlson, Robert G. |
Age-Related Services and Outcomes after DUI Interventions |
University of Michigan |
5/1/09 |
4/30/10 |
$321,761 |
|
Forbis, Shalini G. |
Childhood Asthma Education for Family Care Providers |
Think TV Network (Greater Dayton Public Television) |
11/1/08 |
10/31/09 |
$5,030 |
|
Ford, JoAnn; Moore, Dennis C. |
Our Women's Health Promotion Project (OWHPP) |
DHHS, Substance Abuse and Mental Health Services Administration (SAMHSA) |
9/30/08 |
9/29/09 |
$335,333 |
|
Ford, JoAnn; Moore, Dennis C. |
Healthy Brothers - Healthy Sisters |
DHHS, Substance Abuse and Mental Health Services Administration (SAMHSA) |
9/30/08 |
9/29/09 |
$421,425 |
|
Gebhart, Mark E. |
ACC Emergency Preparedness |
Ohio Department of Health |
7/25/08 |
6/30/09 |
$198,106 |
|
Gebhart, Mark E.; Hamilton, Glenn C. |
ACC Emergency Preparedness |
Ohio Department of Health |
7/1/08 |
6/30/09 |
$1,047,560 |
|
Gebhart, Mark E.; Hamilton, Glenn C. |
Calamityville Campus Project |
Development Projects, Inc. |
12/1/07 |
11/30/09 |
$350,000 |
|
Gebhart, Mark E.; Hamilton, Glenn C. |
Calamityville Campus Project |
Development Projects, Inc. |
12/1/07 |
6/30/09 |
$300,000 |
|
Gentile, Julie P. |
CCOE: Dual Diagnosis: MIMR |
Ohio Department of Mental Health |
7/1/08 |
6/30/09 |
$80,000 |
|
Gentile, Julie P. |
MR/MI Services - Professorship for FY09 |
Montgomery County ADAMH Services Board |
7/1/08 |
6/30/09 |
$30,000 |
|
Gentile, Julie P. |
MR/MI Services - Professorship for FY08 |
Montgomery County ADAMH Services Board |
7/1/07 |
6/30/08 |
$30,000 |
|
Gentile, Julie P. |
FY2009:CCOE-Support from Ohio Department of Mental Retardation |
Ohio Department of Mental Retardation and Developmental Disabilities |
7/1/08 |
6/30/09 |
$75,000 |
|
Gentile, Julie P. |
PROF-MR/DD-ODMRDD FY2009 |
Ohio Department of Mental Retardation and Developmental Disabilities |
7/1/08 |
6/30/09 |
$30,000 |
|
Gentile, Julie P. |
CCOE: Dual Diagnosis MI/MRDD |
Ohio Developmental Disabilities Council |
1/1/09 |
12/31/09 |
$75,000 |
|
Gentile, Julie P. |
Montgomery County MRDD - Professorship for 2009 |
Montgomery County Board of Mental Retardation & Developmental Disabilities |
1/1/09 |
12/31/09 |
$33,696 |
|
Gillig, Paulette M. |
Rural Public Sector Psychiatry - Ohio Department of Mental Health |
Ohio Department of Mental Health |
7/1/08 |
6/30/09 |
$19,623 |
|
Halm, Dan R. |
Regulation of Secretory Ion Channels in Colonic Crypts |
DHHS, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
4/1/09 |
3/31/10 |
$253,351 |
|
Hamilton, Glenn C. |
Calamityville Lab Facility (WPAFB) |
Ohio Board of Regents |
2/1/09 |
6/30/10 |
$3,000,000 |
|
Hangartner, Thomas N. |
Evaluation of a Novel Treatment in Patients with Osteogenesis Imperfecta |
Procter & Gamble Company |
6/1/04 |
5/31/10 |
$1,340 |
|
Hangartner, Thomas N. |
Evaluation of a Novel Treatment in Patients with Osteogenesis Imperfecta |
Procter & Gamble Company |
6/1/04 |
5/31/10 |
$2,184 |
|
Hangartner, Thomas N. |
Evaluation of a Novel Treatment in Patients with Osteogenesis Imperfecta |
Procter & Gamble Company |
6/1/04 |
5/31/10 |
$4,365 |
|
Hangartner, Thomas N. |
Evaluation of a Novel Treatment for Osteoarthritis of the Knee |
Procter & Gamble Company |
8/6/99 |
9/30/08 |
$20,510 |
|
Hangartner, Thomas N. |
Evaluation of a Novel Treatment in Patients with Osteogenesis Imperfecta |
Procter & Gamble Company |
6/1/04 |
5/31/10 |
$1,340 |
|
Hangartner, Thomas N. |
Pharmacogenetics Research Network and Knowledge Base/WSU |
Indiana University |
8/1/08 |
7/31/09 |
$9,970 |
|
Hangartner, Thomas N. |
Characterization of the FlashCT System |
Procter & Gamble Company |
9/1/08 |
12/31/09 |
$55,000 |
|
Hangartner, Thomas N. |
Rare Liver Disease Network |
Children�s Hospital Association (The) |
8/1/08 |
7/31/09 |
$100,000 |
|
Hangartner, Thomas N. |
Evaluation of a Novel Treatment in Patients with Osteogenesis Imperfecta |
Procter & Gamble Company |
6/1/04 |
5/31/10 |
$690 |
|
Hangartner, Thomas N. |
Bone Mineral Density in Childhood Study (BMDCS) |
Clinical Trials & Surveys Corp. |
12/1/06 |
9/30/09 |
$75,435 |
|
Heffernan, Michael P. |
Randomized, Double Blind, Placebo Controlled Study of ABT-874 in Chronic Plaque Psoriasis |
Abbott Laboratories |
10/24/07 |
10/23/11 |
$5,606 |
|
Heffernan, Michael P. |
A Double Blind-Study of Altana Metronidazole Gel to Metrogel and Both to a Control for Treatment of Rosacea |
PharmaNet, LLC |
11/30/07 |
11/29/10 |
$7,592 |
|
Heffernan, Michael P. |
Novel Treatment for Acne Vulgaris |
Kendle NC, Inc. (formerly Charles River Laboratories Clinical Services Inc.) |
7/13/06 |
7/12/08 |
$6,790 |
|
Heffernan, Michael P. |
A Double Blind-Study of Altana Metronidazole Gel to Metrogel and Both to a Control for Treatment of Rosacea |
PharmaNet, LLC |
11/30/07 |
11/29/10 |
$15,160 |
|
Heffernan, Michael P. |
Dermatology Clinical Research Fellowship (Centocor) |
Centocor, Inc. |
7/1/08 |
6/30/09 |
$30,000 |
|
Heffernan, Michael P. |
Psoriasis Longitudinal Assessment and Registry (PSOLAR) |
Centocor, Inc. |
2/1/08 |
1/31/13 |
$2,000 |
|
Heffernan, Michael P. |
Treatment of External Genital Warts |
TKL Research, Inc. |
8/15/08 |
8/14/10 |
$11,852 |
|
Heffernan, Michael P. |
Multi Center, Open-label Study to Assess Infliximab Therapy in Patients with Plaque Psoriasis |
Centocor, Inc. |
7/18/08 |
7/31/10 |
$1,100 |
|
Heffernan, Michael P. |
Randomized, Double Blind, Placebo Controlled Study of ABT-874 in Chronic Plaque Psoriasis |
Abbott Laboratories |
10/24/07 |
10/23/11 |
$2,332 |
|
Heffernan, Michael P. |
Phase 3 Study of Human Monoclonal Antibody against IL-12 in Plaque Psoriasis |
Abbott Laboratories |
5/9/08 |
5/14/12 |
$6,894 |
|
Heffernan, Michael P. |
Randomized, Double Blind, Placebo Controlled Study of ABT-874 in Chronic Plaque Psoriasis |
Abbott Laboratories |
10/24/07 |
10/23/11 |
$31,742 |
|
Heffernan, Michael P. |
Dermatology Clinical Research Fellowship |
Abbott Laboratories |
7/1/08 |
6/30/09 |
$15,000 |
|
Heffernan, Michael P. |
Treatment of External Genital Warts |
TKL Research, Inc. |
8/15/08 |
9/30/09 |
$1,080 |
|
Heffernan, Michael P. |
Clinical Study of ABT-874 as Compared to Etanercept and Placebo in Treatment of Chronic Plaque Psoriasis |
Abbott Laboratories |
9/5/08 |
9/4/09 |
$4,235 |
|
Heffernan, Michael P. |
Randomized, Double Blind, Placebo Controlled Study of ABT-874 in Chronic Plaque Psoriasis |
Abbott Laboratories |
10/24/07 |
10/23/11 |
$8,250 |
|
Heffernan, Michael P. |
Randomized, Double Blind, Placebo Controlled Study of ABT-874 in Chronic Plaque Psoriasis |
Abbott Laboratories |
10/24/07 |
10/23/11 |
$10,390 |
|
Heffernan, Michael P. |
A Double Blind-Study of Altana Metronidazole Gel to Metrogel and Both to a Control for Treatment of Rosacea |
PharmaNet, LLC |
11/30/07 |
9/30/09 |
$18,710 |
|
Heffernan, Michael P. |
Clinical Study of ABT-874 as Compared to Etanercept and Placebo in Treatment of Chronic Plaque Psoriasis |
Abbott Laboratories |
9/5/08 |
9/4/09 |
$5,905 |
|
Heffernan, Michael P. |
Multi Center, Open-label Study to Assess Infliximab Therapy in Patients with Plaque Psoriasis |
Centocor, Inc. |
8/1/08 |
9/30/09 |
$1,700 |
|
Heffernan, Michael P. |
Clinical Study of ABT-874 as Compared to Etanercept and Placebo in Treatment of Chronic Plaque Psoriasis |
Abbott Laboratories |
9/5/08 |
9/4/09 |
$15,290 |
|
Heffernan, Michael P. |
Clinical Study of ABT-874 as Compared to Etanercept and Placebo in Treatment of Chronic Plaque Psoriasis |
Abbott Laboratories |
9/5/08 |
9/4/09 |
$1,480 |
|
Heffernan, Michael P. |
Psoriasis Longitudinal Assessment and Registry (PSOLAR) |
Centocor, Inc. |
3/12/08 |
3/11/13 |
$5,354 |
|
Heffernan, Michael P. |
Randomized, Double Blind, Placebo Controlled Study of ABT-874 in Chronic Plaque Psoriasis |
Abbott Laboratories |
10/24/07 |
9/30/09 |
$2,250 |
|
Heffernan, Michael P. |
Phase 3 Study of Human Monoclonal Antibody against IL-12 in Plaque Psoriasis |
Abbott Laboratories |
5/15/08 |
5/14/12 |
$6,782 |
|
Heffernan, Michael P. |
Randomized, Double Blind, Placebo Controlled Study of ABT-874 in Chronic Plaque Psoriasis |
Abbott Laboratories |
10/24/07 |
10/23/11 |
$9,246 |
|
Kay, Jerald |
Personnel Support for the Wallace-Kettering Neuroscience Institute - Kirbas |
Kettering Medical Center |
7/1/08 |
3/6/09 |
$91,425 |
|
Klykylo, William M. |
Support for Director of Child and Adolescent Psychiatry |
Ohio Department of Mental Health |
7/1/08 |
6/30/09 |
$53,471 |
|
Lee, Miryoung |
Childhood Obesity and Sexual Maturation |
Virginia Commonwealth University |
12/1/08 |
8/31/09 |
$79,909 |
|
Leffak, I. Michael; Liu, Guoqi |
The Role of the DNA Unwinding Element Binding Protein, DUE-B, in DNA Replication |
DHHS, National Institute of General Medical Sciences (NIGMS) |
6/1/09 |
5/31/10 |
$294,145 |
|
Lehrer, Douglas S. |
The Genomic Psychiatry Cohort (GPC) |
University of Southern California |
9/30/08 |
5/31/09 |
$86,100 |
|
Lucot, James B. |
Novel Neuroprotectants for Sarin-induced Neurotoxicity: Post-Exposure Rescue |
Henry M. Jackson Foundation |
7/1/08 |
6/30/09 |
$293,000 |
|
Lucot, James B. |
Chemical Warfare Agent Therapies: Neuroprotectants and Enzyme Reactivators |
Cenomed BioSciences, LLC |
2/1/09 |
3/31/10 |
$13,125 |
|
Lucot, James B.; Schiml-Webb, Patricia |
Collaborative Drug Development Project with Cenomed BioSciences, LLC |
Cenomed BioSciences, LLC |
5/15/09 |
5/14/12 |
$958,275 |
|
Markey, Michael; McDougal, James N. |
Analysis of Gene Expression of Cellular Exposure to Jet Fuel |
Naval Health Research Center |
10/1/08 |
3/31/09 |
$99,370 |
|
Markey, Michael |
Analysis of Desert Sand |
Naval Health Research Center |
9/1/07 |
12/31/09 |
$23 |
|
Markey, Michael |
Regulation and Alternative Transcription of HdmX |
American Cancer Society - Ohio Division |
1/1/09 |
6/30/10 |
$30,000 |
|
McAlearney, John |
Health Reform Outcomes Study |
Ohio State University |
5/1/08 |
12/31/08 |
$38,400 |
|
McDougal, James N. |
Pilot Study of Biomarkers for Hydrocarbon-Induced Skin Tumors |
American Petroleum Institute |
1/1/09 |
6/30/09 |
$35,000 |
|
McDougal, James N. |
In Vitro Toxicity of Engineered Nanomaterials |
Henry M. Jackson Foundation |
5/1/09 |
4/30/10 |
$94,201 |
|
Michail, Sonia K. |
The Use of VSL#3 in Irritable Bowel Syndrome in Children |
DHHS, National Center for Complementary and Alternative Medicine (NCCAM) |
1/1/09 |
12/31/09 |
$157,500 |
|
Moore, Dennis C. |
The Mount Olive One-Stop Center |
DHHS, Substance Abuse and Mental Health Services Administration (SAMHSA) |
9/30/08 |
9/29/09 |
$499,380 |
|
Moore, Dennis C. |
PALS Prevention Project 2009 - Preparing for Prevention Education in the Future |
Ohio Department of Education |
7/1/08 |
6/30/09 |
$72,000 |
|
Moore, Dennis C. |
The Community Health Initiative |
DHHS, Substance Abuse and Mental Health Services Administration (SAMHSA) |
9/30/08 |
9/29/09 |
$254,320 |
|
Moore, Dennis C. |
Strengths-Based Case Management for Positives |
Public Health Dayton and Montgomery County (formerly Montgomery County Combined Health District) |
1/1/09 |
12/31/09 |
$44,034 |
|
Moore, Dennis C. |
RRTC on Substance Abuse, Disability, and Employment |
U.S. Department of Education |
12/1/08 |
11/30/10 |
$699,989 |
|
Morris, Mariana; Elased, Khalid M. |
ACE Balance in the Cardiovascular Complication of Diabetes |
DHHS, National Heart, Lung, and Blood Institute (NHLBI) |
7/1/08 |
5/31/09 |
$348,544 |
|
Morris, Mariana; Chumlea, W. Cameron |
Short-Term Training for Minority Students (STREAMS)/WSU |
DHHS, National Heart, Lung, and Blood Institute (NHLBI) |
9/1/08 |
8/31/09 |
$112,538 |
|
Morris, Mariana; Elased, Khalid M. |
U.S. Brazil Consortia for Biomedical Sciences Exchange |
Wake Forest University |
9/1/08 |
8/31/09 |
$24,364 |
|
Morris, Mariana; Elased, Khalid M. |
ACE Balance in the Cardiovascular Complication of Diabetes |
DHHS, National Heart, Lung, and Blood Institute (NHLBI) |
6/1/09 |
5/31/10 |
$358,750 |
|
Morrison, Ann K. |
Professorship of Community Psychiatry - Ohio Department of Mental Health |
Ohio Department of Mental Health |
7/1/08 |
6/30/09 |
$89,000 |
|
Olson, James E.; Kent, Michael N. |
Nanocontrast Agents |
University of Dayton |
10/1/08 |
6/30/10 |
$22,664 |
|
Organisciak, Daniel T. |
Prevention of Light-Induced Retinal Degeneration by Natural Substances |
Alcon Laboratories, Inc. |
6/15/08 |
6/15/09 |
$173,120 |
|
Organisciak, Daniel T. |
Antioxidants and Retinal Gene Expression Profiles |
Ohio Lions Eye Research Foundation (OLERF) |
7/1/08 |
6/30/09 |
$9,000 |
|
Organisciak, Daniel T. |
Photoreceptor Cell Survival: Continued Studies on the Efficacy of Drug Treatments |
Alcon Laboratories, Inc. |
9/1/08 |
12/31/09 |
$105,127 |
|
Paliy, Oleg; Michail, Sonia K. |
Using Affymetrix Microarrays to Study Microflora Composition in Children with IBS |
DHHS, National Center for Complementary and Alternative Medicine (NCCAM) |
9/30/08 |
6/30/09 |
$215,250 |
|
Part, Howard |
Dayton VAMC Resident Support |
Veterans Affairs Medical Center |
7/1/08 |
6/30/09 |
$2,900,000 |
|
Part, Howard |
Dayton VAMC Resident Support |
Veterans Affairs Medical Center |
7/1/07 |
6/30/08 |
$48,417 |
|
Pascoe, John M. |
ADHD Collaborative Study |
Children�s Hospital Medical Center (Cincinnati) |
6/1/08 |
5/31/09 |
$6,000 |
|
Pascoe, John M.; Chumlea, W. Cameron |
Academic Administrative Unit, Pediatrics |
DHHS, Health Resources and Services Administration (HRSA) |
9/1/08 |
8/31/09 |
$221,942 |
|
Pascoe, John M.; Chumlea, W. Cameron |
Academic Administrative Unit, Pediatrics |
DHHS, Health Resources and Services Administration (HRSA) |
9/1/08 |
8/31/09 |
$19,796 |
|
Pickoff, Arthur S. |
Reach Out of Montgomery County (Fiscal Year 2006/2007) |
Reach Out of Montgomery County |
7/1/06 |
6/30/07 |
$410,279 |
|
Pickoff, Arthur S. |
Reach Out of Montgomery County (Fiscal Year 2008/2009) |
Reach Out of Montgomery County |
7/1/08 |
6/30/09 |
$209,251 |
|
Polenakovik, Hari M. |
Program for Adult Care Excellence (PACE) |
Cystic Fibrosis Foundation |
7/1/08 |
6/30/09 |
$27,000 |
|
Polenakovik, Hari M. |
Program for Adult Care Excellence (PACE) |
Cystic Fibrosis Foundation |
7/1/09 |
6/30/10 |
$27,000 |
|
Prayson, Michael J |
Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH) |
University of Minnesota |
9/15/08 |
8/31/10 |
$3,780 |
|
Putnam, Robert W. |
Intracellular pH Responses of Central Chemoreceptors |
DHHS, National Heart, Lung, and Blood Institute (NHLBI) |
8/1/08 |
7/31/09 |
$278,677 |
|
Rapp, Richard C.; Moore, Dennis C. |
Service Utilization by Frequently Incarcerated Individuals |
Montgomery County Family and Children First Council |
7/15/08 |
12/31/08 |
$12,500 |
|
Rapp, Richard C. |
Cost Effectiveness of Interventions to Reduce Barriers to Drug Abuse Treatment |
University of Arkansas |
3/1/08 |
2/28/09 |
$18,280 |
|
Rapp, Richard C. |
South Carolina Linkage Programs for Inmates |
University of South Carolina |
9/1/08 |
8/31/09 |
$48,208 |
|
Rapp, Richard C.; Moore, Dennis C. |
Service Utilization by Frequently Incarcerated Individuals |
Montgomery County Family and Children First Council |
1/1/09 |
4/30/09 |
$12,500 |
|
Reese, Amanda N.; Olson, James E. |
EMF/SAEM Medical Student Research Grant |
Emergency Medicine Foundation |
7/1/08 |
6/30/09 |
$2,400 |
|
Reo, Nicholas V. |
Metabolomic Assessment of Estrogenic Endocrine Disruptor |
Michigan State University |
6/1/08 |
5/31/09 |
$150,513 |
|
Reo, Nicholas V. |
Metabolomic Assessment of Estrogenic Endocrine Disruptor |
Michigan State University |
6/1/08 |
5/31/09 |
$9,093 |
|
Reo, Nicholas V.; Raymer, Michael L. |
NMR-Based Metabolomics in Toxicology Research |
Henry M. Jackson Foundation |
6/1/06 |
12/31/09 |
$49,960 |
|
Rich, Mark M. |
Loss of Muscle Excitability in Acute Quadriplegic Myopathy |
DHHS, National Institute of Neurological Disorders and Stroke (NINDS) |
3/1/09 |
2/28/10 |
$268,818 |
|
Rich, Mark M. |
Loss of Muscle Excitability in Acute Quadriplegic Myopathy |
DHHS, National Institute of Neurological Disorders and Stroke (NINDS) |
3/1/09 |
8/28/10 |
$29,869 |
|
Sherwood, Richard J. |
The AAOF Craniofacial Growth Legacy Collection: Pilot and Planning Application |
American Association of Orthodontists Foundation |
7/1/08 |
6/30/09 |
$8,000 |
|
Siervogel, Roger M.; Chumlea, W. Cameron |
Adiposity, Disease Risk Factors, and Lifetime Health |
DHHS, National Institute of Child Health and Human Development (NICHD) |
12/1/08 |
11/30/09 |
$1,070,496 |
|
Spears, William D. |
Bexar County Complex Birth Study |
Community First Health Plans, Inc. |
6/1/07 |
1/31/09 |
$5,000 |
|
Spears, William D.; Clasen, Carla |
Strategic Plan Consultant - Improving Health and Educational Outcomes for Youth |
Ohio Department of Education |
12/1/08 |
6/30/09 |
$18,973 |
|
Spears, William D. |
Bexar County Complex Birth Study |
Community First Health Plans, Inc. |
3/1/08 |
2/28/09 |
$5,000 |
|
Sulentic, Courtney E.W. |
3'alpha Enhancer Regulation by AhR and NF-kappaB/Rel Proteins |
DHHS, National Institute of Environmental Health Sciences (NIEHS) |
12/1/08 |
11/30/09 |
$199,343 |
|
Sulentic, Courtney E.W. |
3'alpha Enhancer Regulation by AhR and NF-kappaB/Rel Proteins |
DHHS, National Institute of Environmental Health Sciences (NIEHS) |
12/1/08 |
11/30/09 |
$22,149 |
|
Sulentic, Courtney E.W. |
3'alpha Enhancer Regulation by AhR and NF-kappaB/Rel Proteins |
DHHS, National Institute of Environmental Health Sciences (NIEHS) |
6/1/09 |
10/31/09 |
$6,532 |
|
Towne, Bradford; Czerwinski, Stefan Aleksander |
Genetics of Infant Growth and Later Obesity |
University of Minnesota |
8/1/08 |
7/31/09 |
$83,104 |
|
Trevino, Julian J. |
Immunodermatology Program Development Grant |
Dermatology Foundation |
7/1/08 |
6/30/09 |
$10,000 |
|
Williams, Kimberly Denise; Towne, Bradford |
Genetic Epidemiology of BDA3 in an Endogamous Population |
DHHS, National Institute of Child Health and Human Development (NICHD) |
7/18/08 |
7/17/09 |
$51,278 |
|
Wooley, Dawn P. |
Neutralization of Plague Bacteria by Nanobodies |
Henry M. Jackson Foundation |
8/1/08 |
8/1/09 |
$50,000 |